Influence of Naloxone on Antidepressant Drug Effects in the Forced Swimming Test in Mice

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1984 Jan 1

PMID 6436893

Citations 9

Authors

J L Devoize

F Rigal

A Eschalier

J F Trolese

M Renoux

Affiliations

Soon will be listed here.

Abstract

The influence of naloxone on the effects of several antidepressant drugs, atropine and caffeine was studied in the forced swimming test in mice. Naloxone itself has no effect in this test, but significantly reduces that of two tricyclic antidepressants, clomipramine (20 and 30 mg/kg) and desipramine (20 and 30 mg/kg). Except for clorgyline at the high dose of 60 mg/kg, no significant reduction of activity by naloxone was observed with other antidepressants (pargyline, nomifensine and mianserin), nor with caffeine and atropine. These results are discussed in terms of the pharmacological characteristics of each drug and of the test used. No straightforward interaction between cholinergic or monoaminergic and endorphinic systems is evident. Possible action at opiate receptor sites is discussed.

Citing Articles

Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Deng L, Lee W, Xu Z, Makriyannis A, Hohmann A Pharmacol Res. 2016; 114:75-89.

PMID: 27773824 PMC: 5154848. DOI: 10.1016/j.phrs.2016.10.007.

The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist.

Gassaway M, Rives M, Kruegel A, Javitch J, Sames D Transl Psychiatry. 2014; 4:e411.

PMID: 25026323 PMC: 4119213. DOI: 10.1038/tp.2014.30.

Opioid receptors: distinct roles in mood disorders.

Lutz P, Kieffer B Trends Neurosci. 2012; 36(3):195-206.

PMID: 23219016 PMC: 3594542. DOI: 10.1016/j.tins.2012.11.002.

Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.

Machado-Vieira R, Zarate Jr C Depress Anxiety. 2011; 28(4):267-81.

PMID: 21456037 PMC: 3071576. DOI: 10.1002/da.20800.

Forced swimming test in mice: a review of antidepressant activity.

Petit-Demouliere B, Chenu F, Bourin M Psychopharmacology (Berl). 2004; 177(3):245-55.

PMID: 15609067 DOI: 10.1007/s00213-004-2048-7.

References

Walker J, Berntson G, Paulucci T, Champney T . Blockade of endogenous opiates reduces activity in the rat. Pharmacol Biochem Behav. 1981; 14(1):113-6. DOI: 10.1016/0091-3057(81)90112-x. View

Eschalier A, Montastruc J, Devoize J, Rigal F, Pechadre J . Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. Eur J Pharmacol. 1981; 74(1):1-7. DOI: 10.1016/0014-2999(81)90316-2. View

GORKA Z, Wojtasik E, Kwiatek H, Maj J . Action of serotoninmimetics in the behavioral despair test in rats. Commun Psychopharmacol. 1979; 3(3):133-6. View

Langohr H, Stohr M, Petruch F . An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies. Eur Neurol. 1982; 21(5):309-17. DOI: 10.1159/000115497. View

Lai J, Leung T, Guest J, Lim L, Davison A . The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Biochem Pharmacol. 1980; 29(20):2763-7. DOI: 10.1016/0006-2952(80)90009-x. View

Borsini F, Bendotti C, Velkov V, Rech R, Samanin R . Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants. J Pharm Pharmacol. 1981; 33(1):33-7. DOI: 10.1111/j.2042-7158.1981.tb13697.x. View

Risch S . beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms. Biol Psychiatry. 1982; 17(10):1071-9. View

Lee R, Spencer P . Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J Int Med Res. 1977; 5(1 Suppl):146-56. View

Reisine T, Soubrie P . Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment. Eur J Pharmacol. 1982; 77(1):39-44. DOI: 10.1016/0014-2999(82)90532-5. View

10.

Yaksh T, TYCE G . Resting and K+-evoked release of serotonin and norephinephrine in vivo from the rat and cat spinal cord. Brain Res. 1980; 192(1):133-46. DOI: 10.1016/0006-8993(80)91014-8. View

11.

Le Fur G . [On the proposed mechanism of action of antidepressants (author's transl)]. Encephale. 1980; 6(4):303-13. View

12.

Devoize J, Rigal F, Eschalier A, Trolese J . Naloxone inhibits clomipramine in mouse forced swimming test. Eur J Pharmacol. 1982; 78(2):229-31. DOI: 10.1016/0014-2999(82)90241-2. View

13.

Albouz S, Tocque B, Hauw J, Boutry J, Le Saux F, Bourdon R . Tricyclic antidepressant desipramine induces stereospecific opiate binding and lipid modifications in rat glioma C6 cells. Life Sci. 1982; 31(23):2549-54. DOI: 10.1016/0024-3205(82)90727-5. View

14.

Porsolt R, Bertin A, Blavet N, Deniel M, JALFRE M . Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol. 1979; 57(2-3):201-10. DOI: 10.1016/0014-2999(79)90366-2. View

15.

SCHECHTER M, Chance W . Non-specificity of "behavioral despair" as an animal model of depression. Eur J Pharmacol. 1979; 60(2-3):139-42. DOI: 10.1016/0014-2999(79)90212-7. View

16.

Somoza E, Galindo A, Bazan E, Guillamon A, Valencia A, Fuentes J . Antidepressants inhibit enkephalin binding to synaptosome-enriched fractions of rat brain. Neuropsychobiology. 1981; 7(6):297-301. DOI: 10.1159/000117864. View

17.

Janowsky D, Judd L, Huey L, Roitman N, Parker D, Segal D . Naloxone effects on manic symptoms and growth-hormone levels. Lancet. 1978; 2(8084):320. DOI: 10.1016/s0140-6736(78)91725-7. View

18.

Kastin A, Scollan E, EHRENSING R, Schally A, Coy D . Enkephalin and other peptides reduce passiveness. Pharmacol Biochem Behav. 1978; 9(4):515-9. DOI: 10.1016/0091-3057(78)90051-5. View

19.

Nagy A . Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats. J Pharm Pharmacol. 1977; 29(2):104-7. DOI: 10.1111/j.2042-7158.1977.tb11255.x. View

20.

KLINE N, Li C, Lehmann H, Lajtha A, Laski E, Cooper T . Beta-endorphin--induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry. 1977; 34(9):1111-3. DOI: 10.1001/archpsyc.1977.01770210125012. View